Estrogen Regulates Bone Turnover by Targeting RANKL Expression in Bone Lining Cells
Abstract Estrogen is critical for skeletal homeostasis and regulates bone remodeling, in part, by modulating the expression of receptor activator of NF-κB ligand (RANKL), an essential cytokine for bone resorption by osteoclasts. RANKL can be produced by a variety of hematopoietic (e.g. T and B-cell)...
Guardado en:
Autores principales: | Carmen Streicher, Alexandra Heyny, Olena Andrukhova, Barbara Haigl, Svetlana Slavic, Christiane Schüler, Karoline Kollmann, Ingrid Kantner, Veronika Sexl, Miriam Kleiter, Lorenz C. Hofbauer, Paul J. Kostenuik, Reinhold G. Erben |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8deacb25c8e6455ab90cd1d806872bfd |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Peficitinib improves bone fragility by recovering bone turnover imbalance in arthritic mice
por: Shingo Sugahara, et al.
Publicado: (2022) -
Soluble RANKL contributes to osteoclast formation in adult mice but not ovariectomy-induced bone loss
por: Jinhu Xiong, et al.
Publicado: (2018) -
Correlations between bone turnover markers, serum magnesium and bone mass density in postmenopausal osteoporosis
por: Mederle OA, et al.
Publicado: (2018) -
The relationships between bone turnover markers and bone mineral density in postmenopausal type 2 diabetic women
por: Vadim V. Klimontov, et al.
Publicado: (2016) -
Inhibition of Lipopolysaccharide-Induced Inflammatory Bone Loss by Saikosaponin D is Associated with Regulation of the RANKL/RANK Pathway
por: Wu X, et al.
Publicado: (2021)